Palo Alto Investors’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-495,146
| Closed | -$134K | – | 46 |
|
|
2025
Q1 | $134K | Hold |
495,146
| – | – | 0.03% | 43 |
|
|
2024
Q4 | $257K | Sell |
495,146
-237,254
| -32% | -$123K | 0.04% | 40 |
|
|
2024
Q3 | $2.37M | Hold |
732,400
| – | – | 0.31% | 29 |
|
|
2024
Q2 | $2.2M | Hold |
732,400
| – | – | 0.25% | 30 |
|
|
2024
Q1 | $3.41M | Hold |
732,400
| – | – | 0.38% | 28 |
|
|
2023
Q4 | $3.03M | Hold |
732,400
| – | – | 0.27% | 26 |
|
|
2023
Q3 | $2.2M | Hold |
732,400
| – | – | 0.21% | 22 |
|
|
2023
Q2 | $1.8M | Buy |
732,400
+190,300
| +35% | +$468K | 0.15% | 24 |
|
|
2023
Q1 | $1.23M | Buy |
+542,100
| New | +$1.23M | 0.1% | 27 |
|